Hansa Biopharma AB
OTC:HNSBF
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Hansa Biopharma AB
OTC:HNSBF
|
SE |
|
A
|
Abasca Resources Inc
XTSX:ABA
|
CA |
|
Persistent Systems Ltd
NSE:PERSISTENT
|
IN |
|
Crypto Co
OTC:CRCW
|
US |
|
Allreal Holding AG
F:AZ4N
|
CH |
|
B
|
Bausch Health Companies Inc
F:BVF
|
CA |
|
Aem Holdings Ltd
SGX:AWX
|
SG |
|
G
|
Genfit SA
PAR:GNFT
|
FR |
|
O
|
Oracle Corp Japan
XBER:OCJ
|
JP |
|
4
|
4Basebio PLC
LSE:4BB
|
UK |
|
A
|
Associated British Foods PLC
F:AFO1
|
UK |
|
S
|
Sienna Resources Inc
OTC:SNNAF
|
CA |
|
E
|
EQT Corp
XMUN:EQ6
|
US |
|
Kruk SA
F:83I
|
PL |
Bankruptcy Probability
Hansa Biopharma AB's probability of bankruptcy is Hidden . The solvency score is Hidden .
We take all the information about a company's solvency, such as how easily it can pay interest on outstanding debt, how much cash it has, the amount of debt, and more, and use it to estimate the probability of bankruptcy.
Solvency Ratios
Solvency Ratios Comparison
Hansa Biopharma AB Competitors
| Country | Company | Market Cap | D/E | D/A |
Interest Coverage |
Altman Z-Score |
Quick Ratio |
Current Ratio |
Cash Ratio |
||
|---|---|---|---|---|---|---|---|---|---|---|---|
| SE |
|
Hansa Biopharma AB
STO:HNSA
|
3.3B SEK |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| FR |
|
Pharnext SCA
OTC:PNEXF
|
6T USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| JP |
|
Takara Bio Inc
TSE:4974
|
120.4T JPY |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Abbvie Inc
NYSE:ABBV
|
449.9B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Amgen Inc
NASDAQ:AMGN
|
197.8B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Gilead Sciences Inc
NASDAQ:GILD
|
166.8B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
|
123.5B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
E
|
Epizyme Inc
F:EPE
|
94.1B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
|
71.5B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| NL |
|
argenx SE
XBRU:ARGX
|
46.5B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
S
|
Seagen Inc
F:SGT
|
39.3B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Hansa Biopharma AB's probability of bankruptcy is Hidden .
The probability of bankruptcy is estimated using credit risk models that assess financial health, debt levels, interest coverage, and other solvency indicators.
As of the latest report, Hansa Biopharma AB has total debt of 1.1B SEK. This includes both short-term (0 SEK) and long-term (1.1B SEK) debt.
You can find a full breakdown on its Balance Sheet.
